Finanztrends
Beximco Pharmaceuticals Ltd. GDR Aktie
Heute muss Beximco Pharmaceuticals Ltd. GDR einen mittleren Kursanstieg von 2,13 % verzeichnen.
Was spricht für und gegen Beximco Pharmaceuticals Ltd. GDR in den nächsten Jahren?
Pro
?
U****************
?
M************
?
M****
Kontra
?
L*********** I********** f** d** n******* J****
?
A****************
?
W******* i* V********
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Beximco Pharmaceuticals Ltd. GDR im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 2,13 % | 5,73 % | 6,67 % | 15,94 % | 15,38 % | -20,66 % | -42,86 % |
| SELLAS Life Sciences Group Inc | 3,13 % | 15,60 % | 35,26 % | 112,76 % | 84,27 % | -27,27 % | -74,88 % |
| Eledon Pharmaceuticals Inc. | 13,85 % | 11,28 % | -1,33 % | -65,90 % | -63,73 % | -33,93 % | -90,98 % |
| Check Cap Ltd | 15,04 % | 7,75 % | 15,91 % | 155,00 % | 47,12 % | -47,16 % | 488,46 % |
Kommentare
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%